Both in Pharmaceuticals
Annexon vs Aktis Oncology
Over the past year ANNX returned −20.2% and AKTS returned −33.3%; their daily moves had a correlation of 0.24.
ANNX −20.2% AKTS −33.3%Growth of $1, one year, split-adjusted
| Metric | ANNX | AKTS |
|---|---|---|
| Price | $4.19 | $14.94 |
| Market cap | $794.3M | $831.0M |
| Today | +6.35% | +2.40% |
| 1 month | −0.2% | −19.3% |
| 6 months | −26.7% | −23.1% |
| Year to date | −16.5% | — |
| 1 year | +32.6% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | −713.5% |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $209.2M | $517.3M |
| Dividend yield | — | — |
| Volatility (60d) | 63.8% | 55.5% |
| Short % of float | 20.6% | 18.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).